Plant ID: NPO7672
Plant Latin Name: Senna tora
Taxonomy Genus: Senna
Taxonomy Family: Fabaceae
NCBI TaxonomyDB:
362788
Plant-of-the-World-Online:
n.a.
Anthelmintic; Anticholesterolemic; Antispasmodic; Carminative; Febrifuge; Hepatic; Ophthalmic; Parasiticide; Purgative
Thailand; Nigeria; Indonesia; India; Burkina Faso
TSHR; | |
RECQL; TDP1; BLM; HPGD; HSD17B10; ALOX15; | |
CDC25B; | |
MAPK1; PIM1; CSNK2A1; | |
ESR1; ESR2; | |
ELANE; | |
HIF1A; TP53; NFKB1; | |
LMNA; MAPT; THPO; | |
SMN1;SMN2; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | RECQL | ATP-dependent DNA helicase Q1 | P46063 | CHEMBL1293236 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Enzyme_unclassified | HPGD | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | CHEMBL1293255 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Nuclear hormone receptor subfamily 3 group A | ESR1 | Estrogen receptor alpha | P03372 | CHEMBL206 |
Nuclear hormone receptor subfamily 3 group A | ESR2 | Estrogen receptor beta | Q92731 | CHEMBL242 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Protein Kinase | PIM1 | Serine/threonine-protein kinase PIM1 | P11309 | CHEMBL2147 |
Protein Kinase | CSNK2A1 | Casein kinase II alpha | P68400 | CHEMBL3629 |
Protein Phosphatase | CDC25B | Dual specificity phosphatase Cdc25B | P30305 | CHEMBL4804 |
Serine protease | ELANE | Leukocyte elastase | P08246 | CHEMBL248 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | THPO | Thrombopoietin | P40225 | CHEMBL1293256 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 3.820E-08 | 7.519E-04 | CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008283; cell proliferation | GO:0008284; positive regulation of cell proliferation | 6.906E-08 | 7.519E-04 | CDC25B, CSNK2A1, ELANE, ESR1, HIF1A, HPGD, MAPK1, PIM1, THPO, TSHR |
BP | GO:0009987; cellular process | GO:0000733; DNA strand renaturation | 1.600E-07 | 1.162E-03 | BLM, RECQL, TP53 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 4.181E-07 | 1.821E-03 | CYP2C19, CYP2C9, CYP3A4 |
MF | GO:0060089; molecular transducer activity | GO:0038052; RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | 1.608E-06 | 5.003E-03 | ESR1, ESR2 |
MF | GO:0005488; binding | GO:0042802; identical protein binding | 2.188E-06 | 5.956E-03 | BLM, CSNK2A1, ESR1, ESR2, HPGD, MAPK1, MAPT, NFKB1, SMN1, SMN2, TP53 |
MF | GO:0005488; binding | GO:0051879; Hsp90 protein binding | 9.266E-06 | 9.989E-03 | CSNK2A1, HIF1A, MAPT |
MF | GO:0005488; binding | GO:0034056; estrogen response element binding | 9.634E-06 | 9.989E-03 | ESR1, ESR2 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 9.634E-06 | 9.989E-03 | CYP2C9, CYP3A4 |
BP | GO:0009987; cellular process | GO:0033554; cellular response to stress | 1.020E-05 | 1.010E-02 | ALOX15, BLM, HIF1A, LMNA, MAPK1, MAPT, NFKB1, RECQL, TDP1, TP53 |
CC | GO:0044464; cell part | GO:0005737; cytoplasm | 3.374E-05 | 1.613E-02 | BLM, CYP3A4, ELANE, ESR1, HIF1A, HSD17B10, MAPK1, MAPT, NFKB1, PIM1, RECQL, SMN1, SMN2, TDP1, TP53 |
CC | GO:0044464; cell part | GO:0032838; plasma membrane bounded cell projection cytoplasm | 8.686E-05 | 2.693E-02 | HIF1A, MAPK1, MAPT |
CC | GO:0043226; organelle | GO:0097504; Gemini of coiled bodies | 1.053E-04 | 2.902E-02 | SMN1, SMN2 |
CC | GO:0032991; macromolecular complex | GO:0032797; SMN complex | 1.243E-04 | 3.186E-02 | SMN1, SMN2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 4.414E-08 | 6.092E-06 | CYP2C9, ALOX15, CYP3A4, CYP2C19 |
09150 Organismal Systems | 09152 Endocrine system | hsa04917 | Prolactin signaling pathway | 1.844E-06 | 1.273E-04 | MAPK1, ESR1, NFKB1, ESR2 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04010 | MAPK signaling pathway | 1.397E-05 | 3.856E-04 | MAPK1, MAPT, TP53, NFKB1, CDC25B |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 1.077E-05 | 3.856E-04 | CYP2C9, ALOX15, MAPK1, CYP2C19 |
09150 Organismal Systems | 09152 Endocrine system | hsa04919 | Thyroid hormone signaling pathway | 1.323E-05 | 3.856E-04 | MAPK1, TP53, ESR1, HIF1A |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 2.595E-05 | 5.731E-04 | LMNA, MAPK1, TP53, NFKB1 |
09160 Human Diseases | 09161 Cancers | hsa05206 | MicroRNAs in cancer | 2.907E-05 | 5.731E-04 | PIM1, MAPK1, TP53, NFKB1, CDC25B |
09160 Human Diseases | 09161 Cancers | hsa05221 | Acute myeloid leukemia | 4.828E-05 | 8.329E-04 | PIM1, MAPK1, NFKB1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 6.215E-05 | 9.016E-04 | CYP2C9, ALOX15, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05212 | Pancreatic cancer | 7.495E-05 | 9.016E-04 | MAPK1, TP53, NFKB1 |
09160 Human Diseases | 09161 Cancers | hsa05205 | Proteoglycans in cancer | 1.103E-04 | 1.015E-03 | MAPK1, TP53, HIF1A, ESR1 |
09160 Human Diseases | 09161 Cancers | hsa05202 | Transcriptional misregulation in cancer | 6.924E-05 | 9.016E-04 | HPGD, TP53, ELANE, NFKB1 |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 7.840E-05 | 9.016E-04 | MAPK1, TP53, HIF1A |
09160 Human Diseases | 09161 Cancers | hsa05220 | Chronic myeloid leukemia | 1.013E-04 | 9.984E-04 | MAPK1, TP53, NFKB1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 8.560E-05 | 9.087E-04 | CYP2C9, CYP3A4, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05215 | Prostate cancer | 1.825E-04 | 1.482E-03 | MAPK1, TP53, NFKB1 |
09160 Human Diseases | 09166 Endocrine and metabolic diseases | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 2.652E-04 | 1.926E-03 | PIM1, MAPK1, NFKB1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04915 | Estrogen signaling pathway | 2.500E-04 | 1.917E-03 | MAPK1, ESR1, ESR2 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 1.431E-04 | 1.235E-03 | CYP2C9, CYP3A4, CYP2C19 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04066 | HIF-1 signaling pathway | 2.810E-04 | 1.939E-03 | MAPK1, HIF1A, NFKB1 |
09150 Organismal Systems | 09156 Nervous system | hsa04722 | Neurotrophin signaling pathway | 4.400E-04 | 2.760E-03 | MAPK1, TP53, NFKB1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04071 | Sphingolipid signaling pathway | 4.400E-04 | 2.760E-03 | MAPK1, TP53, NFKB1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05160 | Hepatitis C | 5.941E-04 | 3.430E-03 | MAPK1, TP53, NFKB1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05161 | Hepatitis B | 7.791E-04 | 4.135E-03 | MAPK1, TP53, NFKB1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05162 | Measles | 6.339E-04 | 3.499E-03 | CSNK2A1, TP53, NFKB1 |
09160 Human Diseases | 09161 Cancers | hsa05200 | Pathways in cancer | 1.390E-03 | 6.615E-03 | MAPK1, HIF1A, TP53, NFKB1 |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05010 | Alzheimer's disease | 1.169E-03 | 5.884E-03 | MAPK1, MAPT, HSD17B10 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04024 | cAMP signaling pathway | 1.899E-03 | 8.256E-03 | MAPK1, NFKB1, TSHR |
09160 Human Diseases | 09167 Infectious diseases | hsa05169 | Epstein-Barr virus infection | 1.982E-03 | 8.287E-03 | CSNK2A1, TP53, NFKB1 |
09160 Human Diseases | 09161 Cancers | hsa05203 | Viral carcinogenesis | 2.067E-03 | 8.389E-03 | MAPK1, TP53, NFKB1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05168 | Herpes simplex infection | 1.542E-03 | 7.092E-03 | CSNK2A1, TP53, NFKB1 |
09160 Human Diseases | 09161 Cancers | hsa05213 | Endometrial cancer | 1.914E-03 | 8.256E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05223 | Non-small cell lung cancer | 2.217E-03 | 8.739E-03 | MAPK1, TP53 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04150 | mTOR signaling pathway | 2.540E-03 | 9.473E-03 | MAPK1, HIF1A |
09160 Human Diseases | 09161 Cancers | hsa05219 | Bladder cancer | 1.194E-03 | 5.884E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05216 | Thyroid cancer | 5.966E-04 | 3.430E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05210 | Colorectal cancer | 2.709E-03 | 9.839E-03 | MAPK1, TP53 |
09150 Organismal Systems | 09151 Immune system | hsa04621 | NOD-like receptor signaling pathway | 2.295E-03 | 8.799E-03 | MAPK1, NFKB1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | NFKB1; |
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9; |
C00-D49: Neoplasms | Cancer | C00-C96 | NFKB1; |